Monashee Investment Management LLC Xilio Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.08 - $7.2 $339,177 - $1.17 Million	-163,066 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$6.63 - $16.05 $339,369 - $821,551	-51,187 Reduced 23.89%	163,066 $1.15 Million
Q4 2021 Feb 07, 2022	BUY	$9.69 - $25.11 $2.08 Million - $5.38 Million	214,253 New	214,253 $3.43 Million

14M

Ticker XLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,471,600
Market Cap $24.2M
Description
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.